Vanda Pharmaceuticals (VNDA) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -307.71% |
| Dec 31, 2025 | 237.36% |
| Sep 30, 2025 | 65.16% |
| Jun 30, 2025 | -428.14% |
| Mar 31, 2025 | 366.65% |
| Dec 31, 2024 | 180.07% |
| Sep 30, 2024 | 88.63% |
| Jun 30, 2024 | -108.38% |
| Mar 31, 2024 | 77.59% |
| Dec 31, 2023 | -242.79% |
| Sep 30, 2023 | 116.30% |
| Jun 30, 2023 | -193.16% |
| Mar 31, 2023 | 156.41% |
| Dec 31, 2022 | 1,056.23% |
| Sep 30, 2022 | -1.75% |
| Jun 30, 2022 | -158.89% |
| Mar 31, 2022 | 803.76% |
| Dec 31, 2021 | 124.19% |
| Sep 30, 2021 | 54.15% |
| Jun 30, 2021 | -233.85% |
| Mar 31, 2021 | 174.53% |
| Dec 31, 2020 | 110.56% |
| Sep 30, 2020 | -226.40% |
| Jun 30, 2020 | 52.67% |
| Mar 31, 2020 | 250.04% |
| Dec 31, 2019 | 177.58% |
| Sep 30, 2019 | -160.12% |
| Jun 30, 2019 | 145.71% |
| Mar 31, 2019 | -10,709.16% |
| Dec 31, 2018 | 353.54% |
| Sep 30, 2018 | 99.90% |
| Jun 30, 2018 | -177.56% |
| Mar 31, 2018 | 1,015.55% |
| Dec 31, 2017 | 30.79% |
| Sep 30, 2017 | 241.48% |
| Jun 30, 2017 | 70.98% |
| Mar 31, 2017 | -363.81% |
| Dec 31, 2016 | -19.54% |
| Sep 30, 2016 | 161.57% |
| Jun 30, 2016 | -28.45% |
| Mar 31, 2016 | -398.32% |
| Dec 31, 2015 | 361.57% |
| Sep 30, 2015 | -109.99% |
| Jun 30, 2015 | 155.28% |
| Mar 31, 2015 | -161.61% |
| Dec 31, 2014 | 2,804.21% |
| Sep 30, 2014 | 93.58% |
| Jun 30, 2014 | -22.14% |
| Mar 31, 2014 | 72.22% |
| Dec 31, 2013 | -300.86% |
| Sep 30, 2013 | 711.92% |
| Jun 30, 2013 | -129.77% |
| Mar 31, 2013 | 234.30% |
| Dec 31, 2012 | -255.57% |
| Sep 30, 2012 | 173.89% |
| Jun 30, 2012 | -167.95% |
| Mar 31, 2012 | -26.91% |
| Dec 31, 2011 | 177.78% |
| Sep 30, 2011 | 565.56% |
| Jun 30, 2011 | -121.42% |
| Mar 31, 2011 | 116.63% |
| Dec 31, 2010 | -38.73% |